...
| WMDA Standard | Title and link to document | Explanation | Status |
|---|---|---|---|
8.05 | WMDA recommendation on the use of biosimilar filgrastims | Current (2018) | |
| 3.03 | Blood (2010) 117: 21-25 | This paper describes the reasons that the WMDA continues to believe that HSC donors should not be paid due to ethical concerns raised by remuneration, potential to damage the public will to act altruistically, the potential for coercion and exploitation of donors, increased risk to patients, harm to local transplantation programs and international stem cell exchange, and the possibility of benefiting some patients while disadvantaging others. | Current (2017)Remunation |
| Labeling | |||
Post-donation
| WMDA Standard | Title and link to document | Explanation | Status |
|---|---|---|---|
Towards a global system | |||
...